Guangliang Chen

899 Pinghai Road
Suzhou, 215000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Transcriptional circuits of the glioma microenvironment: FOSL2 as a master regulator of the pathological niche.

Transcriptional circuits of the glioma microenvironment: FOSL2 as a master regulator of the pathological niche.

Journal: Genes & diseases
Published: February 10, 2026

First-in-human phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors, including recurrent or metastatic HNSCC.

First-in-human phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors, including recurrent or metastatic HNSCC.

Journal: BMC medicine
Published: November 28, 2025

Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study.

Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study.

Journal: EClinicalMedicine
Published: March 29, 2025

Ferroptosis-related genes as prognostic markers for survival and immunotherapy in triple-negative breast cancer: analysis of public databases and a single institution.

Ferroptosis-related genes as prognostic markers for survival and immunotherapy in triple-negative breast cancer: analysis of public databases and a single institution.

Journal: Therapeutic advances in medical oncology
Published: October 25, 2024

Purinosomes as a therapeutic target in hepatocellular carcinoma: insights and opportunities.

Purinosomes as a therapeutic target in hepatocellular carcinoma: insights and opportunities.

Journal: Discover oncology
Published: August 27, 2024

PD-1 inhibitors plus chemotherapy for refractory EBV-positive DLBCL: a retrospective analysis.

PD-1 inhibitors plus chemotherapy for refractory EBV-positive DLBCL: a retrospective analysis.

Journal: Blood research
Published: August 16, 2024

Prognostic Significance of Deubiquitinase OTUD7B in NK/T-Cell Lymphoma.

Prognostic Significance of Deubiquitinase OTUD7B in NK/T-Cell Lymphoma.

Journal: Asia-Pacific journal of clinical oncology
Published: July 22, 2024

Reduced OTUD7B expression correlates with poor prognosis in PTCL via non-canonical NF-κB.

Reduced OTUD7B expression correlates with poor prognosis in PTCL via non-canonical NF-κB.

Journal: International journal of hematology
Published: January 27, 2024

TAK-242 inhibits glioblastoma invasion, migration, and proneural-mesenchymal transition by inhibiting TLR4 signaling.

TAK-242 inhibits glioblastoma invasion, migration, and proneural-mesenchymal transition by inhibiting TLR4 signaling.

Journal: Experimental cell research
Published: January 11, 2024

Novel mitochondrial-related gene signature predicts prognosis and immunological status in glioma.

Novel mitochondrial-related gene signature predicts prognosis and immunological status in glioma.

Journal: Translational cancer research
Published: November 09, 2023

Targeting EZH2 regulates the biological characteristics of glioma stem cells via the Notch1 pathway.

Targeting EZH2 regulates the biological characteristics of glioma stem cells via the Notch1 pathway.

Journal: Experimental brain research
Published: February 09, 2023

Heat shock protein 27 deficiency promotes ferrous ion absorption and enhances acyl-Coenzyme A synthetase long-chain family member 4 stability to promote glioblastoma cell ferroptosis.

Heat shock protein 27 deficiency promotes ferrous ion absorption and enhances acyl-Coenzyme A synthetase long-chain family member 4 stability to promote glioblastoma cell ferroptosis.

Journal: Cancer cell international
Published: October 07, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026